Camden National Bank’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.94M Buy
22,050
+7,934
+56% +$3.22M 1.29% 35
2025
Q1
$7.02M Buy
14,116
+3,971
+39% +$1.98M 1.04% 48
2024
Q4
$5.28M Buy
10,145
+40
+0.4% +$20.8K 0.79% 53
2024
Q3
$6.25M Sell
10,105
-105
-1% -$65K 0.9% 52
2024
Q2
$5.65M Buy
10,210
+1,126
+12% +$623K 0.87% 53
2024
Q1
$5.28M Sell
9,084
-172
-2% -$100K 0.93% 51
2023
Q4
$4.91M Sell
9,256
-57
-0.6% -$30.3K 0.91% 52
2023
Q3
$4.71M Buy
9,313
+70
+0.8% +$35.4K 0.97% 52
2023
Q2
$4.82M Buy
9,243
+1,991
+27% +$1.04M 0.94% 52
2023
Q1
$4.18M Buy
7,252
+25
+0.3% +$14.4K 0.85% 57
2022
Q4
$3.98M Sell
7,227
-140
-2% -$77.1K 0.83% 57
2022
Q3
$3.74M Buy
7,367
+44
+0.6% +$22.3K 0.83% 57
2022
Q2
$3.98M Buy
7,323
+53
+0.7% +$28.8K 0.82% 59
2022
Q1
$4.29M Buy
7,270
+77
+1% +$45.5K 0.78% 59
2021
Q4
$4.8M Buy
7,193
+11
+0.2% +$7.34K 0.84% 53
2021
Q3
$4.1M Buy
7,182
+87
+1% +$49.7K 0.79% 54
2021
Q2
$3.58M Sell
7,095
-82
-1% -$41.4K 0.68% 59
2021
Q1
$3.28M Buy
7,177
+121
+2% +$55.2K 0.65% 59
2020
Q4
$3.29M Sell
7,056
-175
-2% -$81.5K 0.68% 57
2020
Q3
$3.19M Buy
7,231
+81
+1% +$35.8K 0.7% 51
2020
Q2
$2.59M Buy
7,150
+6,096
+578% +$2.21M 0.64% 50
2020
Q1
$299K Buy
1,054
+156
+17% +$44.3K 0.08% 96
2019
Q4
$292K Buy
898
+124
+16% +$40.3K 0.06% 110
2019
Q3
$225K Buy
774
+60
+8% +$17.4K 0.05% 113
2019
Q2
$210K Sell
714
-50
-7% -$14.7K 0.05% 112
2019
Q1
$209K Buy
+764
New +$209K 0.05% 107
2018
Q4
Sell
-937
Closed -$229K 112
2018
Q3
$229K Sell
937
-314
-25% -$76.7K 0.06% 99
2018
Q2
$259K Sell
1,251
-127
-9% -$26.3K 0.07% 95
2018
Q1
$285K Buy
+1,378
New +$285K 0.08% 77